Adaptimmune Therapeutics Plc (ADAP) — Free Cash Flow Generation Index
Adaptimmune Therapeutics Plc (ADAP) has a Free Cash Flow Generation Index of 0.98x as of June 2024. Free cash flow of $46.63 Million represents 1% of operating cash flow ($47.39 Million). Read how much debt does Adaptimmune Therapeutics Plc carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Adaptimmune Therapeutics Plc Free Cash Flow Generation Index (2013–2021)
Historical FCF Generation Index trend for Adaptimmune Therapeutics Plc across 2 annual periods. Explore ADAP capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Adaptimmune Therapeutics Plc (2013–2021)
Year-by-year Free Cash Flow Generation Index for Adaptimmune Therapeutics Plc. For the full company profile including market capitalisation, see ADAP stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.18x | $1.95 Million | $10.73 Million | $8.78 Million | ▼ -81.1% |
| 2013 | 0.96x | $35.78 Million | $37.23 Million | $1.45 Million | — |